DOCSLIB.ORG

WT/ACC/SPEC/RUS/21 Página 143 DOCUMENTO DE REFERENCIA 13 Lista De Mercancías Sujetas a Certificación Obligatoria Antes De Su

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
WT/ACC/SPEC/RUS/21 Página 143 DOCUMENTO DE REFERENCIA 13 Lista De Mercancías Sujetas a Certificación Obligatoria Antes De Su WT/ACC/SPEC/RUS/21 Página 143 DOCUMENTO DE REFERENCIA 13 Lista de mercancías sujetas a certificación obligatoria antes de su despacho en el territorio aduanero de la Federación de Rusia (Anexo a la Orden Nº 496, de 14 de agosto, del Comité Estatal de Aduanas de la Federación de Rusia) Parte introductoria La lista de mercancías se representa en un cuadro, cuya columna número 1 incluye los nombres (descripción) de las mercancías, mientras que la columna número 2 incluye los códigos del SA ruso de los apartados en los que están incluidas. La clasificación de mercancías en las partidas específicas del SA ruso se realizará de conformidad con los criterios adoptados en el SA ruso y con las normas de interpretación del SA ruso. Cuando se utilice esta lista, las mercancías se denominarán exclusivamente por sus códigos del SA ruso y en aquellos casos en los que en la columna 2 "Códigos del SA ruso" aparezcan frases como "de...", además de los códigos del SA ruso indicados, se utilizarán como guía los nombres (descripciones) de las mercancías con respecto a las explicaciones dadas en las notas de este cuadro. _________________________________________________________________ ¦ Names (descriptions) of commodities ¦ Russian HS codes ¦ _________________________________________________________________________ ¦ 1 ¦ 2 ¦ _________________________________________________________________________ ¦Meat and edible meat offal*(1) ¦group 02 ¦ _________________________________________________________________________ ¦Fish and crustaceans, molluscs and other aquatic ¦group 03 (except ¦ ¦invertebrates ¦0301 10) ¦ _________________________________________________________________________ ¦Dairy produce; birds' eggs; natural honey ¦group 04 (except ¦ ¦ ¦0407 00 110, ¦ ¦ ¦0407 00 190, ¦ ¦ ¦from 0407 00 900 -¦ ¦ ¦for artificial ¦ ¦ ¦hatching, ¦ ¦ ¦0408 11 200, ¦ ¦ ¦0408 19 200, ¦ ¦ ¦0408 91 200, ¦ ¦ ¦0408 99 200, ¦ ¦ ¦0410 00 000) ¦ _________________________________________________________________________ ¦Semen: ¦ ¦ ¦- bovine undiluted, fresh-obtained or frozen; ¦from 0511 10 000 ¦ ¦- of stallions, undiluted, fresh-obtained or frozen;¦from 0511 99 800 ¦ ¦- of roosters and turkey-cocks, and of rams, fresh- ¦from 0511 99 800 ¦ ¦ obtained ¦ ¦ _________________________________________________________________________ ¦Embryos of bovine animals ¦0511 99 500 ¦ _________________________________________________________________________ ¦Edible vegetables and certain roots and tubers ¦group 07 (except ¦ ¦ ¦0701 10 000, ¦ ¦ ¦0701 90 100, ¦ ¦ ¦0703 10 110, ¦ ¦ ¦from 0703 10 900 -¦ ¦ ¦for sowing ¦ ¦ ¦from 0703 20 000 -¦ ¦ ¦for sowing, ¦ ¦ ¦from 0703 90 000 -¦ ¦ ¦for sowing, ¦ ¦ ¦0711, ¦ ¦ ¦0713 10 100, ¦ ¦ ¦0713 20 100, ¦ ¦ ¦0713 31 100, ¦ ¦ ¦0713 32 100, ¦ ¦ ¦0713 33 100, ¦ ¦ ¦0713 39 100, ¦ WT/ACC/SPEC/RUS/21 Página 144 ¦ ¦0713 40 100, ¦ ¦ ¦0713 50, ¦ ¦ ¦0713 90 100) ¦ _________________________________________________________________________ ¦Forage chickpeas (garbanzos) ¦from 0713 20 900 ¦ _________________________________________________________________________ ¦Forage beans ¦0713 50 900 ¦ _________________________________________________________________________ ¦Edible fruit and nuts ¦group 08 (except ¦ ¦ ¦0812, ¦ ¦ ¦0814 00 000) ¦ _________________________________________________________________________ ¦Coffee, tea, mate and species ¦group 09 ¦ _________________________________________________________________________ ¦Cereals ¦group 10 (except ¦ ¦ ¦1001 90 100, ¦ ¦ ¦from 1001 90 910 -¦ ¦ ¦for sowing, ¦ ¦ ¦from 1002 00 000 -¦ ¦ ¦for sowing, ¦ ¦ ¦1003 00 100, ¦ ¦ ¦1004 00 00 - ¦ ¦ ¦for sowing, ¦ ¦ ¦1005 10, ¦ ¦ ¦1006 10 100, ¦ ¦ ¦1007 00 100, ¦ ¦ ¦from 1008 10 000 -¦ ¦ ¦for sowing, ¦ ¦ ¦from 1008 20 000 -¦ ¦ ¦for sowing, ¦ ¦ ¦1008 30 000, ¦ ¦ ¦from 1008 90 - ¦ ¦ ¦for sowing) ¦ _________________________________________________________________________ ¦Products of the milling-and-grit industry; starches ¦group 11 (except ¦ ¦ ¦1106, 1107, ¦ ¦ ¦1109 00 000) ¦ _________________________________________________________________________ ¦Forage seaweeds, dried and ground ¦from 1212 20 000 ¦ _________________________________________________________________________ ¦Swedes, mangolds, fodder roots, hay, lucerne (alfal-¦1214 ¦ ¦fa), clover, sainfoin, forage kale, lupines, vetches¦ ¦ ¦and similar forage products, whether or not in the ¦ ¦ ¦form of pellets ¦ ¦ _________________________________________________________________________ ¦Animal or vegetable fats and oils and their cleavage¦1501 00 (except ¦ ¦products; prepared edible fats ¦1501 00 110, ¦ ¦ ¦from 1501 00 900 -¦ ¦ ¦for industrial ¦ ¦ ¦uses), ¦ ¦ ¦1502 00 (except ¦ ¦ ¦1502 00 100), ¦ ¦ ¦1507 (except ¦ ¦ ¦1507 10 100, ¦ ¦ ¦1507 90 100), ¦ ¦ ¦1508 (except ¦ ¦ ¦1508 10 100, ¦ ¦ ¦1508 90 100), ¦ ¦ ¦1509 (except ¦ ¦ ¦1509 10 100), ¦ ¦ ¦1510 00, ¦ ¦ ¦1511 (except ¦ ¦ ¦1511 10 100, ¦ ¦ ¦1511 90 910), ¦ ¦ ¦1512 (except ¦ ¦ ¦1512 11 100, ¦ ¦ ¦1512 19 100, ¦ ¦ ¦1512 21 100, ¦ ¦ ¦1512 29 100), ¦ ¦ ¦1513 (except ¦ ¦ ¦1513 11 100, ¦ ¦ ¦1513 19 300, ¦ ¦ ¦1513 21 110, ¦ ¦ ¦1513 21 190, ¦ ¦ ¦1513 29 300), ¦ ¦ ¦1514 (except ¦ ¦ ¦1514 10 100, ¦ WT/ACC/SPEC/RUS/21 Página 145 ¦ ¦1514 90 100), ¦ ¦ ¦1515 (except ¦ ¦ ¦1515 11 000, ¦ ¦ ¦1515 19 100, ¦ ¦ ¦1515 21 100, ¦ ¦ ¦1515 29 100, ¦ ¦ ¦1515 30, ¦ ¦ ¦1515 40 000, ¦ ¦ ¦1515 50 110, ¦ ¦ ¦1515 50 910, ¦ ¦ ¦1515 60, ¦ ¦ ¦1515 90), ¦ ¦ ¦1516 (except ¦ ¦ ¦1516 20 100, ¦ ¦ ¦1516 20 950), ¦ ¦ ¦1517 ¦ _________________________________________________________________________ ¦Natural drying oil ¦from 1518 00 ¦ _________________________________________________________________________ ¦Preparations of meat, of fish or of crustaceans, ¦group 16 (except ¦ ¦molluscs or other aquatic invertebrates ¦1603 00) ¦ _________________________________________________________________________ ¦Sugar and sugar confectionery ¦1701 91 000, ¦ ¦ ¦1701 99 100, ¦ ¦ ¦1704 ¦ _________________________________________________________________________ ¦Cocoa and cocoa preparations ¦1805 00 000, ¦ ¦ ¦1806 (except ¦ ¦ ¦1806 90 900) ¦ _________________________________________________________________________ ¦Preparations of cereals, flour, starch or milk; ¦1901 10 000, ¦ ¦pastrycook's products ¦1901 20 000, ¦ ¦ ¦1902, ¦ ¦ ¦1903 00 000, ¦ ¦ ¦1904, ¦ ¦ ¦1905 (except ¦ ¦ ¦1905 90 200) ¦ _________________________________________________________________________ ¦Preparations of vegetables, fruit, nuts or other ¦from group 20 ¦ ¦parts of plants for retail sale ¦ ¦ _________________________________________________________________________ ¦Miscellaneous edible preparations (except food addi-¦2101 (except ¦ ¦tives and biologically active food additives - ¦2101 12 980, ¦ ¦nutriceutics *(2) ¦2101 20 980, ¦ ¦ ¦2101 30 190, ¦ ¦ ¦2101 30 990), ¦ ¦ ¦2103 10 000, ¦ ¦ ¦2103 20 000, ¦ ¦ ¦2103 30 900, ¦ ¦ ¦2103 90, ¦ ¦ ¦2104, ¦ ¦ ¦from 2105 00 - ¦ ¦ ¦ice cream, whether¦ ¦ ¦or not containing ¦ ¦ ¦cocoa ¦ _________________________________________________________________________ ¦Inactive yeasts and single-cell algae, of a kind ¦from 2102 20 110, ¦ ¦used for animal feed ¦from 2102 20 190, ¦ ¦ ¦from 2102 20 900 ¦ _________________________________________________________________________ ¦Beverages, spirits and vinegar ¦2201 (except ¦ ¦ ¦2201 90 000), ¦ ¦ ¦2202, ¦ ¦ ¦2203 00 (except- ¦ ¦ ¦2203 00 100), ¦ ¦ ¦2204 *(3), ¦ ¦ ¦2205 *(3), ¦ ¦ ¦2206 00 (except ¦ ¦ ¦2206 00 810, ¦ ¦ ¦2206 00 890), ¦ ¦ ¦from220710000 *(4)¦ ¦ ¦- potable alcohol,¦ ¦ ¦2208 20 (except ¦ ¦ ¦2208 20 400, ¦ ¦ ¦2208 20 620, ¦ ¦ ¦2208 20 640, ¦ ¦ ¦2208 20 860, ¦ WT/ACC/SPEC/RUS/21 Página 146 ¦ ¦2208 20 870, ¦ ¦ ¦2208 20 890), ¦ ¦ ¦2208 30 (except ¦ ¦ ¦2208 30 190, ¦ ¦ ¦2208 30 380, ¦ ¦ ¦2208 30 580, ¦ ¦ ¦2208 30 780, ¦ ¦ ¦2208 30 880), ¦ ¦ ¦2208 40 (except ¦ ¦ ¦2208 40 900), ¦ ¦ ¦2208 50 (except ¦ ¦ ¦2208 50 190, ¦ ¦ ¦2208 50 990), ¦ ¦ ¦2208 60 (except ¦ ¦ ¦2208 60 190, ¦ ¦ ¦2208 60 990), ¦ ¦ ¦2208 70 (except ¦ ¦ ¦2208 70 900) ¦ ¦ ¦2208 90 (except ¦ ¦ ¦2208 90 190, ¦ ¦ ¦2208 90 380, ¦ ¦ ¦2208 90 710, ¦ ¦ ¦2208 90 740, ¦ ¦ ¦2208 90 780, ¦ ¦ ¦2208 90 910, ¦ ¦ ¦2208 90 990), ¦ ¦ ¦2209 00 (except ¦ ¦ ¦2209 00 190, ¦ ¦ ¦2209 00 990) ¦ _________________________________________________________________________ ¦Residues and waste from the food industries; ¦group 23 (except ¦ ¦prepared animal fodder ¦2307 00, ¦ ¦ ¦2308 90) ¦ _________________________________________________________________________ ¦Tobacco and manufactured tobacco substitutes ¦group 24 (except ¦ ¦ ¦2401, 2402 90 000,¦ ¦ ¦2403 10 900, ¦ ¦ ¦2403 99 900) ¦ _________________________________________________________________________ ¦Salt suitable for human consumption in packings ¦from 2501 00 910 ¦ ¦of not more than 2 kg ¦ ¦ _________________________________________________________________________ ¦Rock salt, of a kind used for animal feed*(5) ¦from 2501 00 990 ¦ _________________________________________________________________________ ¦Limestone for the manufacture of mixed fodder for ¦from 2509 00 000 ¦ ¦agricultural animals and poultry and for additional ¦ ¦ ¦feeding of poultry (chalk)*(5) ¦ ¦ _________________________________________________________________________ ¦Aviation spirit ¦2710 00 260 ¦ _________________________________________________________________________ ¦Motor spirit ¦2710 00 270 - ¦ ¦ ¦2710 00 360 ¦ _________________________________________________________________________ ¦Kerosene (jet fuel) ¦2710 00 510 ¦ _________________________________________________________________________ ¦Diesel fuel for other purposes ¦2710 00 690 ¦ ¦Liquid fuels (mazut) for other purposes ¦2710 00 740 ¦ ¦ ¦2710 00 780 ¦ _________________________________________________________________________
Load more

Recommended publications
  • Ozone Therapy: Beyond Oxygen the Most Needed Adjunct to Veterinary Medicine Introduction of Ozone
    Ozone Therapy: Beyond Oxygen The Most Needed Adjunct to Veterinary Medicine Introduction of Ozone Margo Roman, D.V.M., CVA, COT, CPT MASH Main St Animal Services of Hopkinton Hopkinton MA 01748 www.mashvet.com • OZONE is a trivalent oxygen molecule. Three O2 + electrical spark/ lightning= 2 O3. It is very reactive and will return to 3 O2 molecules giving high levels of O2. Healthy cells need Oxygen • Ozone is one of the most beneficial substances on this planet, and the BAD science you hear quoted on the news every night is causing you to subconsciously be afraid of nature, and therefore, a part of life itself. They tell you that somehow hydrogen plus nitrogen or sulfur equals ozone. H + N + S = 03? Not on this planet it doesn't! What is ozone? Simply, oxygen. Three atoms of nature's oxygen. It exists in a very active form for about 30 minutes before breaking down into two atoms of regular oxygen - by giving up one atom of singlet oxygen. Where does ozone come from? Nature. And nature is efficient. The new growth in the forests, the trees, the grass on your front lawn, and the plankton in the ocean are continually creating oxygen. • • If you have seen Inconvenient Truth, the Al Gore documentary on Global warming, there is one scene that brings it all together. In one section he discusses the CO2 levels over the Pacific Ocean. In addition to the original measurements that began in 1965, they were able to measure the levels from hundreds of years ago by taking samples from deep within glaciers.
    [Show full text]
  • Ozone Therapy Has Been Utilized and Heavily Studied for More Than a Century
    Ozone Ozone is a therapy that delivers oxygen at the cellular level aiding your body to be more Therapy powerful and to function better under stress. “Ozone therapy has been utilized and heavily studied for more than a century. Its effects are proven, consistent, safe and with minimal and preventable side effects. Medical ozone is used to disinfect and treat disease. Mechanism of actions is by inactivation of bacteria, viruses, fungi, yeast, and protozoa, stimulation of oxygen metabolism, activation of the immune system.” Elvis, A.M. Ozone Therapy: A Clinical Review. Journal of Natural Science, Biology, and Medicine. 2011 Jan-Jun; 2(1):66-70. What is Ozone is a naturally occurring gas that has very useful medical applications. Ozone OZONE (O3)? can also be produced from medical grade oxygen and use of an ozone generator. Ozone in small concentrations is safe and effective in preventing and treating a host of different illnesses and diseases. The oxygen that we breathe and circulate in our bodies contain two oxygen atoms (O2). Ozone is made up of three oxygen atoms (O3). You may be wondering how does ozone change into oxygen? An ozone molecule is eager to give away one of its oxygen atoms. When two of the "freed up" oxygen atoms connect and bond together a new oxygen molecules is created; O + O => O2 (oxygen!). This process is called oxidation. Vitality Medical Infusions Ozone Therapy 1/3 If Ozone is so Ozone is not a "drug" that can be patented by drug companies & BIG PHARMA. It’s a Beneficial why natural substance that can also be produced inexpensively.
    [Show full text]
  • Ozone in Medicine. the Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases
    International Journal of Molecular Sciences Article Ozone in Medicine. The Low-Dose Ozone Concept and Its Basic Biochemical Mechanisms of Action in Chronic Inflammatory Diseases Renate Viebahn-Haensler 1,*,† and Olga Sonia León Fernández 2,*,† 1 Medical Society for the Use of Ozone in Prevention and Therapy, Iffezheim, D-76473 Baden-Baden, Germany 2 Pharmacy and Food Institute, University of Havana, Coronela, Lisa, Havana 10 400, Cuba * Correspondence: [email protected] (R.V.-H.); [email protected] (O.S.L.F.) † Both authors contributed equally. Abstract: Low-dose ozone acts as a bioregulator in chronic inflammatory diseases, biochemically char- acterized by high oxidative stress and a blocked regulation. During systemic applications, “Ozone peroxides” are able to replace H2O2 in its specific function of regulation, restore redox signaling, and improve the antioxidant capacity. Two different mechanisms have to be understood. Firstly, there is the direct mechanism, used in topical treatments, mostly via radical reactions. In systemic treatments, the indirect, ionic mechanism is to be discussed: “ozone peroxide” will be directly reduced by the glutathione system, informing the nuclear factors to start the regulation. The GSH/GSSG balance outlines the ozone dose and concentration limiting factor. Antioxidants are regulated, and in the case of inflammatory diseases up-regulated; cytokines are modulated, here downregulated. Rheumatoid Citation: Viebahn-Haensler, R.; arthritis RA as a model for chronic inflammation: RA, in preclinical and clinical trials, reflects the León Fernández, O.S. Ozone in pharmacology of ozone in a typical manner: SOD (superoxide dismutase), CAT (catalase) and finally Medicine. The Low-Dose Ozone GSH (reduced glutathione) increase, followed by a significant reduction of oxidative stress.
    [Show full text]
  • Complementary and Alternative Medicine Table of Contents Related Coverage Resources
    Medical Coverage Policy Effective Date ............................................. 2/15/2021 Next Review Date ....................................... 2/15/2022 Coverage Policy Number .................................. 0086 Complementary and Alternative Medicine Table of Contents Related Coverage Resources Overview.............................................................. 1 Acupuncture Coverage Policy .................................................. 1 Atherosclerotic Cardiovascular Disease Risk General Background ........................................... 3 Assessment: Emerging Laboratory Evaluations Medicare Coverage Determinations .................. 36 Attention-Deficit/Hyperactivity Disorder (ADHD): Coding/Billing Information ................................. 37 Assessment and Treatment References ........................................................ 39 Autism Spectrum Disorders/Pervasive Developmental Disorders: Assessment and Treatment Biofeedback Chiropractic Care Drug Testing Hyperbaric and Topical Oxygen Therapies Physical Therapy INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies. Please
    [Show full text]
  • Cigna Medical Coverage Policy
    Cigna Medical Coverage Policy Subject Complementary and Effective Date ............................ 7/15/2014 Alternative Medicine Next Review Date……………….7/15/2015 Coverage Policy Number ................. 0086 Table of Contents Hyperlink to Related Coverage Policies Coverage Policy .................................................. 1 Acupuncture General Background ........................................... 3 Attention Deficit/Hyperactivity Disorder Coding/Billing Information ................................. 21 (ADHD): Assessment and Treatment References ........................................................ 23 Autism Spectrum Disorders/Pervasive Developmental Disorders: Assessment and Treatment Biofeedback Atherosclerotic Cardiovascular Disease Risk Assessment: Emerging Laboratory Evaluations Chiropractic Care Hyperbaric Oxygen Therapy, Systemic & Topical INSTRUCTIONS FOR USE The following Coverage Policy applies to health benefit plans administered by Cigna companies. Coverage Policies are intended to provide guidance in interpreting certain standard Cigna benefit plans. Please note, the terms of a customer’s particular benefit plan document [Group Service Agreement, Evidence of Coverage, Certificate of Coverage, Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans upon which these Coverage Policies are based. For example, a customer’s benefit plan document may contain a specific exclusion related to a topic addressed in a Coverage Policy. In the event of a conflict, a customer’s
    [Show full text]
  • Trigeminal Neuralgia
    www.biogenericpublishers.com Article Type: Research Article Received: 25/06/2020 Published: 07/07/2020 DOI: 10.46718/JBGSR.2020.02.000056 Ozone Therapy in the Treatment of Symptoms Associated to Trigeminal Neuralgia Ioana Soare1 and Roxana Mirica2* 1Associate Professor, primary care physician for medical expertise and work capacity recovery, Faculty of Medicine, Titu Maiorescu University of Bucharest, Romania 2Assistant Professor, primary care physician for medical expertise and work capacity recovery, Carol Davila Medicine and Pharmacy University of Bucharest, Romania *Corresponding author: Mirica, Assistant Professor, primary care physician for medical expertise and work capacity recovery, certified for Bach flower remedies, Carol Davila Medicine and Pharmacy University of Bucharest, 60,Grigore Alexandrescu street, District 1, zip code 010626, Bucharest, Romania ORCID ID: 0000-0003-0068-3895 Abstract Background Trigeminal neuralgia: Manifests as an extremely intense neuropathic pain that affects the patient’s life in all its aspects. The classical -according to the guides -treatment with Carbamazepine has various adverse reactions. Patients have a low compliance too, and stop the treatment. Analgesia through acupuncture was thoroughly studied in the meta-analysis conducted by Vickers et al. on 20,827 patients in 2017. We propose ozone therapy on trigger points as treatment, the antialgic effect of acupuncture being doubled with the trophic effect of the oxygen. Treatment, the antialgic effect of acupuncture being doubled with the trophic effect of the oxygen. Measures: A 54 years old patient with hemicrania and hypersensitivity on the right side of the face, who spoke with his mouth almost closed, after 12 sessions of ozone therapy, felt no pain, the symptoms were significantly improved.
    [Show full text]
  • Oxidation Attendees List for Website Revised 07-25-17
    I am pleased to post a listing of health professionals my wife and I have personally trained in oxidation methods. Please note that this is a partial list only. Others might not want their names listed for business, legal, or other reasons. You might go to www.acam.org or www.icimed.org to look for a listing of integrative doctors in your area. Many list some form of oxidation therapy in their practice summary on these sites. Generally these doctors will know who in their area offers oxidation. I have included contact information, the date of training with us (if available), and specific oxidation techniques these professionals currently offer, as these professionals so informed me. I will update this list as more are trained, or more previously trained indicate that they wish to be listed. Please note that I have limited the listing of services provided here to those services related to oxidation only. Most, if not all of these fine healers will offer chelation, other IV and detoxification services, and perhaps many other healing modalities. I have not listed those services here. Any physician wise enough to use oxidation, in my humble opinion, will offer a great home for overall healing. Please note that high dose intravenous (IV) vitamin C is an oxidation therapy! (UV and UBI connote ultraviolet blood irradiation therapy). (OHT is intravenous ozone high dose therapy, the same as “10 pass”.) DIV is direct intravenous ozone gas administration. Listing by state or country is in alphabetical order. Please look at each for closest. USA Arizona Brian Archambault NMD West Valley Naturopathic Center 1646 N.
    [Show full text]
  • Complementary and Alternative Medicine
    Corporate Medical Policy Complementary and Alternative Medicine File Name: complementary_and_alternative_medicine Origination: 12/2007 Last CAP Review: 2/2021 Next CAP Review: 2/2022 Last Review: 2/2021 Description of Procedure or Service The National Center for Complementary and Integrative Medicine (NCCIH), a component of the National Institutes of Health, defines complementary, alternative medicine (CAM) as a group of diverse medical and health care systems, practices, and products that are not presently considered to be part of conventional or allopathic medicine. While some scientific evidence exists regarding some CAM therapies, for most there are key questions that are yet to be answered through well-designed scientific studies-questions such as whether these therapies are safe and whether they work for the diseases or medical conditions for which they are used. Complementary medicine is used together with conventional medicine. Complementary medicine proposes to add to a proven medical treatment. Alternative medicine is used in place of conventional medicine. Alternative means the proposed method would possibly replace an already proven and accepted medical intervention. NCCIM classifies CAM therapies into 5 categories or domains: • Whole Medical Systems. These alternative medical systems are built upon complete systems of theory and practice. These systems have evolved apart from, and earlier than, the conventional medical approach used in the U.S. Examples include: homeopathic and naturopathic medicine, Traditional Chinese Medicine, Ayurveda, Macrobiotics, Naprapathy and Polarity Therapy. • Mind-Body Medicine. Mind-body interventions use a variety of techniques designed to enhance the mind’s capacity to affect bodily functions and symptoms. Some techniques have become part of mainstream practice, such as patient support groups and cognitive-behavioral therapy.
    [Show full text]
  • Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects
    antioxidants Review Modulation of Oxidative Stress by Ozone Therapy in the Prevention and Treatment of Chemotherapy-Induced Toxicity: Review and Prospects Bernardino Clavo 1,2,3,4,5,* , Francisco Rodríguez-Esparragón 1 , Delvys Rodríguez-Abreu 6, Gregorio Martínez-Sánchez 7, Pedro Llontop 8 , David Aguiar-Bujanda 9 , Leandro Fernández-Pérez 4 and Norberto Santana-Rodríguez 4,10,11 1 Research Unit, Dr. Negrín University Hospital, 35019 Las Palmas de Gran Canaria, Spain; [email protected] 2 Chronic Pain Unit, Dr. Negrín University Hospital, 35019 Las Palmas de Gran Canaria, Spain 3 Radiation Oncology Department, Dr. Negrín University Hospital, 35019 Las Palmas de Gran Canaria, Spain 4 Universitary Institute for Research in Biomedicine and Health (IUIBS), Molecular and Translational Pharmacology Group, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain; [email protected] (L.F.-P.); [email protected] (N.S.-R.) 5 Spanish Group of Clinical Research in Radiation Oncology (GICOR), 28290 Madrid, Spain 6 Medical Oncology Department, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, University of Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain; [email protected] 7 Scientific Advisor, Freelance, 60126 Ancona, Italy; [email protected] 8 Experimental Medicine and Surgery Unit of Hospital Gregorio Marañon and the Health Research Institute of Hospital Gregorio Marañon (IiSGM), 28007 Madrid, Spain; [email protected] 9 Medical Oncology Department,
    [Show full text]
  • Apresentação Do Powerpoint
    Are the integrative practices recently incorporated into the Brazilian public healthcare system supported by evidence from Cochrane Reviews? Riera R1,2, Dittrich NH1, Pacheco RL1,3, Latorraca COC1, Martimbianco ALC3,4, Atallah AN1,5 1 Universidade Federal de São Paulo (Unifesp), Brazil 2 Hospital Sírio-Libanês, Brazil 3 Centro Universitário São Camilo, Brazil 4 Universidade Metropolitana de Santos (UNIMES), Brazil 5 Cochrane Brazil, Brazil The Problem Methods In March 2018, the Brazilian Ministry of Health announced 10 new integrative practices as part of the list of procedures available in the Brazilian public healthcare system, Sistema Único de Saúde (SUS). SUS, a free and universal system, has a limited budget, and all interventions should be fairly supported by good Apitherapy quality studies before its implementation. We summarized the evidence from Cochrane Reviews (CRs) Aromatherapy about these 10 interventions [1]. Bioenergetics Family constellation Key Results Chromotherapy Clay therapy Search was carried out in March 2018: 189 reviews. 16 CRs were included. Only 4 of the 10 integrative Hypnotherapy practices (apitherapy, aromatherapy, hypnotherapy and ozone therapy). For six integrative Hand imposition interventions (bioenergetics, family constellation, chromotherapy, geotherapy, flower therapy, and Ozone therapy hand imposition), no CR was found. The certainty of evidence ranged from unknown to high. The high- Flower therapy certainty evidence: honey dressings for partial thickness burns, honey for acute cough in children, and venom immunotherapy for systematic reaction to an insect sting. Almost the totality of the new interventions incorporated by Brazilian Ministry of Health in 2018 are not support by evidence from Cochrane Reviews. Sensitive search strategy Table 1.
    [Show full text]
  • Increasing the Effectiveness of Intravenous Vitamin C As an Anticancer Agent
    JOM Volume 30, Number 1, 2015 Educational Article 45 Increasing the Effectiveness of Intravenous Vitamin C as an Anticancer Agent Michael J. Gonzalez NMD, DSc, PhD, FANMA, FACN;1 Jorge R. Miranda-Massari PharmD;2 Jorge Duconge PhD;2 Miguel J. Berdiel MD;3 1,2University of Puerto Rico, Medical Sciences Campus, RECNAC 2 Project, Schools of Public Health and Phar- macy3 Pontifical Catholic University, Dept. of Biology. *Correspondence should be addressed to: Dr. Michael J Gonzalez, University of Puerto Rico, Medical Sciences Campus School of Public Health, Department of Human Development, Nutrition Program, GPO Box 365067 San Juan PR 00936-5067; email: [email protected] Abstract Vitamin C has been mentioned as an agent with chemotherapeutic potential since 1952. Physiological concentrations of vitamin C (L-ascorbate or L-ascorbic acid) in the body are controlled through intestinal absorption, tissue accumulation, and renal reabsorption and excretion. Therefore, intravenous administration is used to achieve pharmacologic doses not attainable by other means. In relation to intravenous administration of ascorbate, high-dose intravenous vitamin C (>0.5 g/kg body weight) has several effects: cytotoxicity for cancer cells but not for normal cells; improved quality of life for cancer patients; protection of normal tissues from toxicity caused by chemotherapy; rein- forcement of the action of radiation and some types of chemotherapy; immune system enhancement; and strengthening of collagen and hyaluronic acid. In this article we discuss important therapeutic variables that the clinician faces that are key for increasing the effectiveness of intravenous vitamin C as an anticancer agent. Introduction d. Increases appetite.
    [Show full text]
  • Effectiveness of Acupuncture, Ozonio Therapy and Low-Intensity Laser in the Treatment of Temporomandibular Dysfunction of Muscle
    Original Article © 2018 - ISSN 1807-2577 Effectiveness of acupuncture, ozonio therapy and low-intensity laser in the treatment of temporomandibular dysfunction of muscle origin: a randomized controlled trial Efetividade da acupuntura, ozonioterapia e do laser de baixa intensidade no tratamento da disfunção temporomandibular de origem muscular: um ensaio clínico randomizado Síglia Adriana Campos TORTELLIa , Leonardo SARAIVAa* , Daniela Cristina MIYAGAKIa aUPF – Universidade de Passo Fundo, Passo Fundo, RS, Brasil How to cite: Tortelli SAC, Saraiva L, Miyagaki DC. Effectiveness of acupuncture, ozonio therapy and low-intensity laser in the treatment of temporomandibular dysfunction of muscle origin: a randomized controlled trial. Rev Odontol UNESP. 2019;48:e20190107. https://doi.org/10.1590/1807-2577.10719 Resumo Introdução: Uma das causas mais comuns de dores orofaciais é a disfunção temporomandibular (DTM). Objetivo: O objetivo deste estudo foi comparar a efetividade da acupuntura, ozonioterapia e laserterapia no tratamento de pacientes com DTM muscular, através de um ensaio clínico randomizado. Material e método: Foram avaliados 12 professores e estudantes de pós-graduação da Universidade de Passo Fundo, diagnosticados com DTM, com faixa etária entre 23 e 50 anos, de ambos os sexos. Os indivíduos foram divididos aleatoriamente em 3 grupos: G1: laserterapia, G2: acupuntura, e G3: ozonioterapia. Foram aplicados questionários de diagnóstico de DTM (RDC/TMD), questionário de Qualidade de Vida (OHIP-14), Escala de dor (EVA) e mensuração de abertura bucal máxima. Para caracterização da amostra, utilizaram-se estatísticas descritivas e percentagem, que foram apresentadas empregando-se distribuições de frequências absolutas e relativas. As variáveis qualitativas foram analisadas com os testes de Wilcoxon Resultado: Não houve diferença estatisticamente significativa entre os tratamentos.
    [Show full text]